Most people assume an insurance denial is the end of the story. It isn’t. Learn why appeals succeed more often than you think, why so few patients file them, and discover a free, plain-English guide to navigating denials, deadlines, and your rights before you give up.

At the 2026 Robert A. Winn Clinical Investigator Symposium, hundreds of medical students received We the Patients and were challenged to see healthcare from the patient side of the bed rail, including the burden, bureaucracy, and hidden labor that medical training too often ignores.

A new tracker shows that 86% of Congress took campaign money from major health insurance PACs. The biggest checks went to the lawmakers with the most power over healthcare policy, raising a brutal question: who exactly is Congress working for when patients are being denied care?

UnitedHealthcare invited journalists to headquarters to burnish its image. Then its CEO dismissed wrongful death lawsuits as “one-offs.” That phrase says everything about a system where denial, delay, and patient harm are treated as isolated incidents instead of the business model.

Dr. Jessica Peatross spent years inside hospital medicine before realizing many chronically ill patients improved only after leaving the system behind. In this episode, she unpacks mold exposure, overmedication, functional medicine, and why patients keep losing trust in healthcare.

OncoDaily named 100 influential cancer survivors for 2026. Matthew Zachary explains why the honor matters, why it’s bittersweet, and what survivor visibility really means for newly diagnosed patients looking for proof they’re not alone.

Concierge medicine used to be for the rich. Now ordinary patients are paying out of pocket for advocates, navigators, and direct access just to get the care their insurance was supposed to provide in the first place. Welcome to the second bill nobody asked for.

Every major source of patient data in this country is compromised by whoever paid for it. The We The Patients National Patient Perspectives Poll changes that. 5 minutes. Anonymous. The data belongs to patients, not institutions.

Retail executive and breast cancer survivor Farla Efros approached cancer the same way she rescued struggling companies: with strategy, discipline, and relentless preparation. She explains why patients are forced to become CEOs of their own care and why the system rewards those who can.

Every year I leave ASCO with hundreds of selfies that become one giant mosaic. This year’s image tells a bigger story than the science alone. It captures the people, conversations, and growing realization that the next challenge in cancer care isn’t discovery. It’s making sure patients can reach it.

A retired firefighter’s denied cancer treatment reveals a larger truth about American healthcare. Administrative friction has become an economic strategy that shifts costs onto patients and physicians while delaying care in ways the system rarely measures but patients always feel.

Americans now need books to survive healthcare. That’s not evidence of empowerment. It’s evidence of failure. As affordability collapses and complexity grows, patients are being forced to become advocates, navigators, and administrators just to access care they already pay for.

Long COVID did not create a crisis. It exposed one. Patients without clear diagnoses lose access to care, coverage, and credibility. When medicine cannot measure your illness, the system moves on. Here is what that looks like and who pays the price

US healthcare does not fail when it denies care. It performs as designed. This essay involving the life of Jace Yawnick examines how insurance incentives, prior authorization, and employer based coverage shape access, delay treatment, and shift risk onto patients while increasing total cost.

ASCO 2026 delivered extraordinary advances in cancer research, including a standing ovation for a pancreatic cancer breakthrough. Yet the dominant conversation centered on something else: the widening gap between scientific innovation and patients’ ability to access it.

Brain cancer at 21 forced Matthew Zachary into the American healthcare system decades before he understood its economics, incentives, and failures. At 52, he reflects on how surviving long enough to see the whole machine clearly led to writing We the Patients.

Cancer patients increasingly absorb the financial risk of surviving disease in America. A brain cancer survivor examines how healthcare incentives, insurance design, and policy decisions shifted instability onto patients and families while institutions protect margins.

Patients now need executive level skills to survive diagnosis, treatment, and access. This essay featuring Kathy Giusti breaks down how healthcare incentives create that reality, who benefits, who pays, and what must change to reduce risk and restore accountability.

Thirty years after brain cancer, Matthew Zachary returned to the piano at Merkin Hall for MZLIVE, a night that became far more than a concert. Survivors, advocates, clinicians, and healthcare leaders confronted what survivorship actually costs and what the system still refuses to see